Abstract:Conventional antiangiogenetic inhibitors suffered from poor delivery problems that result in unsatisfactory antitumor treatment efficacy. Although the liposomes or nanomaterial-based delivery systems can improve the therapeutic efficacy of antiangiogenic molecules, the assembly process is far too complex. Herein, a nanomaterial or a new nanodrug that could work without the help of a carrier and could be easily synthesized is needed. Au nanoclusters (AuNCs) are a kind of ideal nanostructures that could spontaneously enter into the cell and could be synthesized by a relatively easy one-pot method. Here, changing the traditional ligand glutathione (GSH) into an anti-Flt1 peptide (AF) has enriched the newly synthesized with targeted antiangiogenic properties. Based on the specific binding between AF and vascular endothelial growth factor receptor 1 (VEGFR1), the interaction between VEGFR1 and its ligands could be blocked. Furthermore, the expression of VEGFR2 could be downregulated. Compared with pure AF peptide- and GSH-participated AuNCs (), were more effective in inhibiting both tube formation and migration of the endothelial cells in vitro. Furthermore, the in vivo chick embryo chorioallantoic membrane (CAM) experiment and antitumor experiment were conducted to further verify the enhanced antiangiogenesis and tumor inhibition effect of Our findings provide promising evidence of a carrier-free nanodrug for tumors and other vascular hyperproliferative diseases.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.1c01164?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.1c01164</a>.Additional information as noted in the text, including the fluorescence quantum yield of ; cytotoxicity of on HUVECs; characterization of the proportion of cell uptake of by flow cytometry; inhibition of on endothelial cell tubular morphogenesis (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c01164/suppl_file/am1c01164_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Research on the in Vitro Anticancer Activity and in Vivo Tissue Distribution of Amoitone B Nanocrystals

Studies on the preparation, characterization and pharmacokinetics of Amoitone B nanocrystals

Preparation, Characterization and Pharmacokinetics of Amoitone B-loaded Long Circulating Nanostructured Lipid Carriers.

In vitro and in vivo study of BZG-4000: Anti-tumoral activity of human hepatocellular carcinoma

Design and characterization of Amoitone B-loaded nanostructured lipid carriers for controlled drug release.

A Novel Bone Marrow Targeted Gadofullerene Agent Protect Against Oxidative Injury in Chemotherapy

Preparation, Characterization and in Vitro–in Vivo Evaluation of Bortezomib Supermolecular Aggregation Nanovehicles

Preparation and in vitro antitumor effects on MDA-MB-231 cells of niclosamide nanocrystals stabilized by poloxamer188 and PBS

Systemic delivery of the anticancer agent arenobufagin using polymeric nanomicelles

Novel nano-vehicle for delivery and efficiency of anticancer auraptene against colon cancer cells

Biomimetic Boron Nitride Nanoparticles for Targeted Drug Delivery and Enhanced Antitumor Activity

Design, Synthesis and Biological Evaluation of Nitrogen-Containing Macrocyclic Bisbibenzyl Derivatives As Potent Anticancer Agents by Targeting the Lysosome.

Enhanced antitumor effect of icariin nanoparticles coated with iRGD functionalized erythrocyte membrane

Development and in vitro evaluation of carmustine delivery platform: A hypoxia-sensitive anti-drug resistant nanomicelle with BBB penetrating ability

Superior Anticancer Efficacy of Curcumin-Loaded Nanoparticles Against Lung Cancer.

Nanocrystal-loaded liposome for targeted delivery of poorly water-soluble antitumor drugs with high drug loading and stability towards efficient cancer therapy

Application of Cell Membrane-Coated Nanomaterials for Tumor Treatment.

Synthesis and Antitumor Application of Antiangiogenetic Gold Nanoclusters

Synthesis, Characterization and in Vitro Anticancer Activity of the Biomolecule-Based Coordination Complex Nanotubes

Evaluation of Pluronic Nanosuspensions Loading a Novel Insoluble Anticancer Drug Both in Vitro and in Vivo.

Drug Nanocrystals for Active Tumor-Targeted Drug Delivery